New Project (1)

Day: February 3, 2022

George Clinical Accredited for Gene Technology Clinical Research

SYDNEY, Feb. 03, 2022 (GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs). The addition of this capability  means that George Clinical can now, […]

Read More »

FloQast Celebrates 2021 as Landmark Year for Company Growth

Fueled by a Successful Series D Funding Round and Hiring Campaign, FloQast Continues Building Momentum Throughout Q4 with Massive YoY Growth Rate LOS ANGELES, Feb. 03, 2022 (GLOBE NEWSWIRE) — FloQast, a provider of accounting workflow automation software created by accountants for accountants, today announced its Q4 and 2021 metrics, concluding a milestone year highlighted […]

Read More »

Connected Capital Closes €154 Million Second Fund Targeting European B2B SaaS Scale-Ups as Global Demand for Cloud Software Grows

Amsterdam-based Private Equity Firm’s Second Fund is 3x Size of Previous Fund and Brings Total Assets to over €200 Million; New Fund Makes Connected Capital The Largest Pure-Play B2B SaaS Investor in Europe Connected Capital team AMSTERDAM, Feb. 03, 2022 (GLOBE NEWSWIRE) — Connected Capital, a leading investor exclusively targeting European B2B SaaS businesses, today […]

Read More »

Ingredion Incorporated Reports 2021 Results; Expects 7% to 9% Operating Income Growth for 2022

Fourth quarter 2021 reported and adjusted EPS* were $0.99 and $1.09, respectively, compared to fourth quarter 2020 reported and adjusted EPS of $1.70 and $1.75, respectively. Full-year 2021 reported and adjusted EPS were $1.73 and $6.67, respectively, compared with $5.15 and $6.23 in the year-ago period, respectively. Reported results for full-year 2021 include a $340 […]

Read More »


 Recent Post


February 2022